Julius Strauss MD

Julius Strauss received his MD from Stony Brook University Medical Center School of Medicine in 2010 and completed his internal medicine residency at Montefiore Medical Center in 2013. He joined the NCI Medical Oncology Service as a Medical Oncology Fellow in 2013. Dr Strauss is Director of the Clinical Trials Group of the Laboratory of Tumor Immunology and Biology, NCI. He also has an adjunct appointment in the Genitourinary Malignancies Branch of the NCI. He is board certified in medical oncology and internal medicine.

His clinical research is focused on the use of novel agents capable of inducing the immune system to recognize and kill cancer cells. Dr Strauss is very interested in the use of these agents in combination with each other as well as “standard” cytotoxic therapies in an effort to improve their efficacy. Dr Strauss also has an interest in using these therapies to help patients with the fewest treatment options, including patients with rare diseases. Dr Strauss’s areas of expertise include immunotherapy, therapeutic cancer vaccines, and immune checkpoint inhibitors. Dr Strauss is part of the larger effort of the Laboratory of Tumor Immunology and Biology to create new immunotherapies for the treatment of cancer.